Prescription Formulations Catalog
Explore genuine clinical retinoic acid formulations (0.025%, 0.05%, 0.1%), microsphere clarifying gels, and specialized dermatological treatments dispensed directly to Australian patients.
Available Formulations
Topical retinoic acid creams, clarifying gels, and targeted pigment treatments in therapeutic concentrations.
Tretinoin Cream 0.025%
Lowest concentration cream for initial retinoid therapy. Suitable for patients starting treatment or with sensitive skin.
Tretinoin Cream 0.05%
Standard maintenance concentration for acne and photoaging. Prescribed after skin tolerates 0.025% without ongoing irritation.
Tretinoin Cream 0.1%
Highest concentration cream. Formulated for patients who have built tolerance to 0.05% and require stronger treatment for persistent acne.
Tretinoin Gel 0.025%
Alcohol-based gel formulation that dries without residual oil. Formulated for oily or comedone-prone skin types.
Tretinoin Gel 0.05%
Moderate strength gel formulation for oily skin and inflammatory acne lesions. Absorbs rapidly into the skin.
Tretinoin Gel 0.1%
High concentration gel for stubborn acne in patients with high retinoid tolerance and oily skin.
Azelaic Acid 20% Cream
Topical treatment that reduces cutibacterium acnes proliferation, inflammation, and abnormal pigmentation.
Hydroquinone 4% Cream
Reversible depigmenting agent that inhibits enzymatic oxidation of tyrosine to 3,4-dihydroxyphenylalanine.
Retinoid Starter Set
Three-product regimen containing Tretinoin Cream 0.025% (30g), a ceramide barrier cream (50ml), and broad-spectrum SPF 50+ sunscreen (50ml).
Concentration Guide & Clinical Selection
Select a concentration based on prior retinoid tolerance, skin barrier resilience, and primary dermatological indication.
For new patients or sensitive skin types.
- Initial concentration for first-time retinoid users
- Lower frequency of dryness, redness, and flaking
- Used to build skin tolerance over 6 to 8 weeks
- Suitable for thin or reactive skin barriers
For established acne or photoaging.
- Most commonly prescribed maintenance concentration
- For comedonal and mild inflammatory acne
- Improves fine facial wrinkles and skin texture
- Recommended after tolerating 0.025% comfortably
For persistent acne or severe photoaging.
- Highest concentration topical retinoic acid
- For stubborn acne unresponsive to lower doses
- Only suitable for skin fully adapted to 0.05%
- Higher likelihood of initial dryness
Important Contraindications and Retinoid Safety
Topical retinoic acid is an active pharmaceutical substance. Please review the clinical safety directives below prior to initiating treatment.
Pregnancy Contraindication
Topical tretinoin and hydroquinone are strictly contraindicated during pregnancy, planned conception, and lactation. Discontinue immediately if pregnancy is suspected.
Mandatory Sun Protection
Retinoids accelerate cellular turnover and increase UV vulnerability. Apply broad-spectrum SPF 50+ sunscreen every morning and reapply as directed during sun exposure.
Acclimatization & Side Effects
Mild peeling, dryness, and erythema are expected during weeks 1–4. Introduce therapy every 2–3 nights initially. Avoid AHA, BHA, or harsh scrubs while adapting.
Application Buffering Method (Sandwich Technique)
If you experience dryness, redness, or tightness during the initial weeks, utilize this three-step buffering method to minimize irritation.
Cleanse and Moisturize
Wash gently with a mild cleanser. Apply a light layer of plain moisturizer to damp skin, then allow 15 minutes to dry completely.
Apply Pea-Sized Amount
Dispense a single pea-sized drop for the entire face. Smooth evenly, keeping clear of eyelids, nostrils, and lips.
Seal and Protect
Allow 5 minutes to absorb, then apply a second layer of moisturizer over top. Always apply broad-spectrum SPF 50+ each morning.